VolitionRX Limited (NYSEAMERICAN:VNRX – Get Free Report) shares crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.30 and traded as low as $0.27. VolitionRX shares last traded at $0.2932, with a volume of 723,487 shares traded.
VolitionRX Price Performance
The company has a market capitalization of $36.00 million, a PE ratio of -1.27 and a beta of 1.23. The stock’s 50 day simple moving average is $0.30 and its 200-day simple moving average is $0.50.
About VolitionRX
VolitionRX, traded as VNRX on the NYSE American exchange, is a pioneering life sciences company focused on the development and commercialization of minimally invasive diagnostic tests for the early detection of cancer and other diseases. Utilizing proprietary technology to analyze circulating nucleosomes in blood samples, the company’s platform identifies disease-specific epigenetic and biochemical signatures. By offering blood-based screening solutions, VolitionRX aims to deliver alternatives to invasive, costly and time-consuming procedures, potentially improving patient outcomes through earlier diagnosis.
The company’s flagship product suite, branded as Nu.Q, comprises assays designed to detect biomarkers associated with a range of malignancies, including colorectal, lung and pancreatic cancers, as well as other systemic conditions.
See Also
- Five stocks we like better than VolitionRX
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for VolitionRX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRX and related companies with MarketBeat.com's FREE daily email newsletter.
